Gryska David W's Form 4 filing
Seagen Inc. (SGEN) · filed Apr 21, 2022
- Accession no.
- 0001203311-22-000021
- Filed
- Apr 21, 2022
- Trade date
- Apr 19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $575.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gryska David WCIK 0001202335 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | Common Stock | MOption exerciseAcquired | +1,794 | $20.06 | +$35,987.64 | 48,044 | Direct | |
| Apr 19, 2022 | Common Stock | SSaleDisposed | −1,794 | $143.32F3 | −$257,116.08 | 46,250 | Direct | |
| Apr 19, 2022 | Common Stock | MOption exerciseAcquired | +1,516 | $20.06 | +$30,410.96 | 47,766 | Direct | |
| Apr 19, 2022 | Common Stock | SSaleDisposed | −1,516 | $144.17F4 | −$218,561.72 | 46,250 | Direct | |
| Apr 19, 2022 | Common Stock | MOption exerciseAcquired | +690 | $20.06 | +$13,841.4 | 46,940 | Direct | |
| Apr 19, 2022 | Common Stock | SSaleDisposed | −690 | $145.08F5 | −$100,105.2 | 46,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | Common Stock | MOption exerciseDisposed | −1,794 | $0.00 | $0 | 2,206 | Direct | |
| Apr 19, 2022 | Common Stock | MOption exerciseDisposed | −1,516 | $0.00 | $0 | 690 | Direct | |
| Apr 19, 2022 | Common Stock | MOption exerciseDisposed | −690 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $142.84 to $143.82. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $143.84 to $144.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects sales of common stock executed in multiple transactions at prices ranging from $144.91 to $145.40. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.